Classifying hepatitis C virus genotypes.
Hepatitis C virus (HCV) is the major aetiological agent for blood-borne non-A, non-B hepatitis worldwide. Since its discovery in 1989, at least 28 HCV genotypes have been reported, which differ by > 20% in the nucleotide sequence of the entire genome (approximately 9500 nucleotides) or the sequence of the E1 gene (576 nucleotides). Different HCV genotypes have distinct geographical distributions, and may be associated with variations in viral replication and disease-inducing activity, as well as poor response to interferons in patients with chronic hepatitis C.
Miyakawa
Y
Y
Mita Institute, Tokyo, Japan.
Okamoto
H
H
Mayumi
M
M
D005821:Genetic Techniques; D005843:Geography; D016174:Hepacivirus / Q000145:classification* / Q000187:drug effects / Q000235:genetics*; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D014761:Viral Hepatitis Vaccines
D014761:Viral Hepatitis Vaccines; D007372:Interferons